Clinical Trials

Myasthenia gravis

Displaying 3 studies

RESET-MG: A Study To Evaluate The Safety And Efficacy Of CABA-201 In Participants With Generalized Myasthenia Gravis Jacksonville, FL; Rochester, MN
RESET-MG: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Participants with Generalized Myasthenia Gravis
A Study To Evaluate The Effectiveness And Safety Of Rozanolixizumab In Adult Patients With Generalized Myasthenia Gravis Rochester, MN

The purpose of this study is to demonstrate the clinical effectiveness and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG).
A Study To Evaluate Rozanolixizumab To Treat Patients With Generalized Myasthenia Gravis Rochester, MN

The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study participants with generalized myasthenia gravis.